SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $1,386,000 | -24.9% | 126,571 | -27.6% | 0.00% | -33.3% |
| Q1 2017 | $1,845,000 | -21.7% | 174,874 | -37.7% | 0.00% | -25.0% |
| Q4 2016 | $2,356,000 | +23.7% | 280,505 | +5.4% | 0.00% | +33.3% |
| Q3 2016 | $1,905,000 | +19.8% | 266,123 | +28.7% | 0.00% | 0.0% |
| Q2 2016 | $1,590,000 | +23.9% | 206,715 | +17.8% | 0.00% | +50.0% |
| Q1 2016 | $1,283,000 | -12.4% | 175,458 | -7.6% | 0.00% | 0.0% |
| Q4 2015 | $1,465,000 | -23.5% | 189,981 | -29.0% | 0.00% | -33.3% |
| Q3 2015 | $1,914,000 | -10.6% | 267,652 | +32.8% | 0.00% | 0.0% |
| Q2 2015 | $2,140,000 | +8.2% | 201,546 | +26.1% | 0.00% | 0.0% |
| Q1 2015 | $1,978,000 | +126.6% | 159,787 | +70.8% | 0.00% | +200.0% |
| Q4 2014 | $873,000 | +37.3% | 93,546 | +47.4% | 0.00% | 0.0% |
| Q3 2014 | $636,000 | -7.4% | 63,449 | -4.7% | 0.00% | 0.0% |
| Q2 2014 | $687,000 | -19.2% | 66,594 | -2.5% | 0.00% | 0.0% |
| Q1 2014 | $850,000 | +85.2% | 68,272 | +83.0% | 0.00% | 0.0% |
| Q4 2013 | $459,000 | – | 37,311 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Senvest Management, LLC | 2,988,261 | $25,759,000 | 2.86% |
| NORTH TIDE CAPITAL, LLC | 2,150,000 | $18,533,000 | 1.94% |
| HOURGLASS CAPITAL, LLC | 838,900 | $7,231,000 | 1.26% |
| Baupost Group | 4,000,000 | $34,480,000 | 0.98% |
| DAFNA Capital Management LLC | 90,947 | $784,000 | 0.86% |
| PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. | 573,108 | $4,940,000 | 0.77% |
| Visium Asset Management, LP | 3,405,000 | $29,351,000 | 0.67% |
| PERRITT CAPITAL MANAGEMENT INC | 380,000 | $3,276,000 | 0.64% |
| Leonard Capital Management, Inc. | 112,109 | $966,000 | 0.38% |
| BRANDES INVESTMENT PARTNERS, LP | 1,765,018 | $15,214,000 | 0.20% |